Biotechnology Services

Grifols’ shares plunge further on short-seller’s new report

Carib Chronicles March 6, 2024 0

Grifols shares plunged by a further 14% on Wednesday following publication of another report from short seller Gotham City Research,...

Opinion: We’re spending more on leisure and travel. These 11 stocks will soak it up.

Carib Chronicles February 26, 2024 0

Leisure stocks are likely to outperform this year as emboldened consumers kick back and relax. Here’s more on three economic...

Enphase’s ‘good enough’ quarter pushes stock 12% higher

Carib Chronicles February 7, 2024 0

Enphase Energy Inc. shares jumped more than 12% in the extended session Tuesday after the alternative-energy company presented investors with...

SolarEdge to lay off 16% of its workforce as part of cost-cutting plan

Carib Chronicles January 21, 2024 0

SolarEdge Technologies Inc. on Sunday said it will lay off about 16% of its workforce, about 900 employees, as part of...

GSK to buy asthma drug developer for up to $1.4 billion in pipeline push

Carib Chronicles January 9, 2024 0

GSK on Tuesday said it had struck a deal to acquire asthma drug developer Aiolos Bio for up to $1.4...

Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships

Carib Chronicles January 8, 2024 0

Nvidia Corp. NVDA, +4.69% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc....

Enphase’s stock keeps falling after longtime bull abandons buy call

Carib Chronicles January 4, 2024 0

Shares of Enphase Energy Inc. fell again on Thursday after a longtime bullish analyst recommended investors stop buying, given the...

Ozempic parent Novo Nordisk to collaborate with Omega and Cellarity on obesity treatments

Carib Chronicles January 4, 2024 0

Novo Nordisk has entered research collaboration agreements with Omega Therapeutics Inc. and Cellarity Inc. on new treatments for obesity management,...